Ruediger P Laubender
Overview
Explore the profile of Ruediger P Laubender including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Greif M, von Ziegler F, Wakili R, Tittus J, Becker C, Helbig S, et al.
Clin Res Cardiol
. 2013 Apr;
102(8):555-62.
PMID: 23584714
Introduction: Pericardial adipose tissue (PAT), a visceral fat depot surrounding the heart, serves as an endocrine active organ and is associated with inflammation. There is growing evidence that atrial fibrillation...
12.
Giessen C, Laubender R, Fischer von Weikersthal L, Schalhorn A, Modest D, Stintzing S, et al.
Cancer Sci
. 2013 Mar;
104(6):718-24.
PMID: 23480146
Early tumor shrinkage (ETS) has been highlighted as a favorable prognostic factor related to progression-free survival (PFS) and overall survival (OS) in cytotoxic treatment of metastatic colorectal cancer. Data from...
13.
Pomschar A, Koerte I, Lee S, Laubender R, Straube A, Heinen F, et al.
PLoS One
. 2013 Feb;
8(2):e55447.
PMID: 23405151
Purpose: To compare venous drainage patterns and associated intracranial hydrodynamics between subjects who experienced mild traumatic brain injury (mTBI) and age- and gender-matched controls. Methods: Thirty adult subjects (15 with...
14.
Rochat M, Laubender R, Kuster D, Braendli O, Moeller A, Mansmann U, et al.
PLoS One
. 2013 Jan;
8(1):e52619.
PMID: 23320075
Background: Spirometry reference values are important for the interpretation of spirometry results. Reference values should be updated regularly, derived from a population as similar to the population for which they...
15.
Modest D, Laubender R, Stintzing S, Giessen C, Schulz C, Haas M, et al.
Acta Oncol
. 2012 Dec;
52(5):956-62.
PMID: 23244709
Purpose: This study investigated the impact of early tumor shrinkage (ETS) on progression-free- (PFS) and overall survival (OS) in patients with metastatic colorectal cancer (mCRC) treated within the AIO KRK...
16.
Modest D, Brodowicz T, Stintzing S, Jung A, Neumann J, Laubender R, et al.
Oncology
. 2012 Sep;
83(5):241-7.
PMID: 22948721
Purpose: This study investigated the impact of specific mutations in codon 12 of the Kirsten-ras (KRAS) gene on treatment efficacy in patients with metastatic colorectal cancer (mCRC). Patients: Overall, 119...
17.
Grunke M, Witt M, Ronneberger M, Schnez A, Laubender R, Engelbrecht M, et al.
J Rheumatol
. 2012 Jun;
39(7):1334-40.
PMID: 22660799
Objective: Joint counts are the key outcome measure in rheumatoid arthritis (RA). There is a great variability between different assessors of the same patient; this variability can be reduced by...
18.
Haas M, Laubender R, Klose C, Schulz C, Mansmann U, Boeck S, et al.
Pancreas
. 2012 Jan;
41(5):738-44.
PMID: 22286380
Objectives: The objective of this study was to perform an external validation of 2 Asian prognostic indices for patients with advanced pancreatic cancer. Methods: A score was calculated in patients...
19.
Ertl-Wagner B, Koerte I, Kumpfel T, Blaschek A, Laubender R, Schick M, et al.
Mult Scler
. 2011 Dec;
18(7):1000-7.
PMID: 22194216
Objective: There is an on-going controversy about venous drainage abnormalities in multiple sclerosis (MS). We applied cardiac-gated phase-contrast and venographic magnetic resonance (MR) techniques to compare venous drainage patterns in...
20.
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status
Modest D, Stintzing S, Laubender R, Neumann J, Jung A, Giessen C, et al.
Anticancer Drugs
. 2011 Jul;
22(9):913-8.
PMID: 21795973
This retrospective study investigated the clinical characteristics of patients with metastatic colorectal cancer (mCRC) depending on the KRAS status, thereby differentiating KRAS exon 2 mutations in codon 12 versus codon...